KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.
出版信息
Clin Mol Hepatol. 2013 Dec;19(4):325-48. doi: 10.3350/cmh.2013.19.4.325. Epub 2013 Dec 28.
Abstract
摘要
相似文献
1
KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.
Clin Mol Hepatol. 2013 Dec;19(4):325-48. doi: 10.3350/cmh.2013.19.4.325. Epub 2013 Dec 28.
2
Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management.
Am Fam Physician. 2020 Nov 15;102(10):603-612.
3
Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?
JAMA. 2012 Aug 8;308(6):608-16. doi: 10.1001/jama.2012.8402.
4
[The importance of AST / ALT rate in nonalcoholic steatohepatitis diagnosis].
Arq Gastroenterol. 2002 Jan-Mar;39(1):22-6. doi: 10.1590/s0004-28032002000100005.
5
Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Nutrition. 2015 Jul-Aug;31(7-8):923-30. doi: 10.1016/j.nut.2014.11.018. Epub 2014 Dec 24.
6
Nonalcoholic fatty liver disease: a systematic review.
JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370.
7
Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
Turk J Gastroenterol. 2018 Mar;29(2):170-176. doi: 10.5152/tjg.2018.17297.
8
Impact of physical activity on nonalcoholic steatohepatitis in people with nonalcoholic simple fatty liver: A prospective cohort study.
Prev Med. 2016 Jul;88:237-40. doi: 10.1016/j.ypmed.2016.04.020. Epub 2016 Apr 30.
9
Application of Machine Learning Methods to Predict Non-Alcoholic Steatohepatitis (NASH) in Non-Alcoholic Fatty Liver (NAFL) Patients.
AMIA Annu Symp Proc. 2018 Dec 5;2018:430-439. eCollection 2018.
10
Nonalcoholic fatty liver disease: defining a common problem.
Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5):253-9.
引用本文的文献
1
Barriers to care linkage and educational impact on unnecessary MASLD referrals.
Front Med (Lausanne). 2024 Jul 25;11:1407389. doi: 10.3389/fmed.2024.1407389. eCollection 2024.
2
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study.
Liver Cancer. 2023 Dec 22;13(4):426-437. doi: 10.1159/000535943. eCollection 2024 Aug.
3
Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population.
Sci Rep. 2024 Apr 29;14(1):9753. doi: 10.1038/s41598-024-60152-0.
4
Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends.
Sci Rep. 2024 Jan 8;14(1):799. doi: 10.1038/s41598-023-50190-5.
5
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut-Liver-Heart Crosstalk.
Nutrients. 2023 Sep 14;15(18):3970. doi: 10.3390/nu15183970.
6
Neck Circumference as a Predictor of Insulin Resistance in People with Non-alcoholic Fatty Liver Disease.
J Obes Metab Syndr. 2023 Sep 30;32(3):214-223. doi: 10.7570/jomes22066. Epub 2023 Aug 31.
7
Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans.
Asian Biomed (Res Rev News). 2022 Feb 28;16(1):15-22. doi: 10.2478/abm-2022-0003. eCollection 2022 Feb.
8
Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry.
J Liver Cancer. 2021 Mar;21(1):58-68. doi: 10.17998/jlc.21.1.58. Epub 2021 Mar 31.
9
Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study.
Sci Rep. 2023 Mar 23;13(1):4724. doi: 10.1038/s41598-023-31686-6.
10
Fatty Liver and Risk of Head and Neck Cancer in Type 2 Diabetes Mellitus: A Nationwide Cohort Study.
Cancers (Basel). 2023 Feb 14;15(4):1209. doi: 10.3390/cancers15041209.
本文引用的文献
1
Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography.
Radiology. 2013 Aug;268(2):411-9. doi: 10.1148/radiol.13121193. Epub 2013 Apr 5.
2
Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study.
Arch Med Res. 2013 Feb;44(2):115-20. doi: 10.1016/j.arcmed.2013.01.007. Epub 2013 Feb 8.
3
A critical appraisal of advances in pediatric nonalcoholic Fatty liver disease.
Semin Liver Dis. 2012 Nov;32(4):317-24. doi: 10.1055/s-0032-1329905. Epub 2013 Feb 8.
4
The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study.
Atherosclerosis. 2013 Apr;227(2):398-403. doi: 10.1016/j.atherosclerosis.2013.01.002. Epub 2013 Jan 18.
5
Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study.
Hepatology. 2013 Apr;57(4):1378-83. doi: 10.1002/hep.26183.
6
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.
Hepatology. 2013 Apr;57(4):1357-65. doi: 10.1002/hep.26156. Epub 2013 Jan 25.
7
Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease.
J Hepatol. 2012 Dec;57(6):1312-8. doi: 10.1016/j.jhep.2012.07.027. Epub 2012 Aug 4.
8
Medical complications of bariatric surgery: focus on malabsorption and dumping syndrome.
Dig Dis. 2012;30(2):182-6. doi: 10.1159/000336681. Epub 2012 Jun 20.
9
Diagnosis and management of acute and early complications of/after bariatric surgery.
Dig Dis. 2012;30(2):178-81. doi: 10.1159/000336677. Epub 2012 Jun 20.
10
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
Liver Int. 2012 Jul;32(6):911-8. doi: 10.1111/j.1478-3231.2012.02820.x.
Zotero 插件